Morgan Stanley Call 7925 PX1 21.0.../ DE000MB7VSL2 /
15/05/2024 12:57:14 | Diferencia-0.06 | Bid13:43:22 | Ask13:43:22 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
1.48EUR | -3.90% | 1.51 Volumen de oferta: 100,000 |
1.52 Tamaño/ Volumen/ Formato de Ask: 100,000 |
CAC 40 | 7,925.00 - | 21/06/2024 | Call |
Newsfile Corp
14:00
Burcon Expands US Investor Outreach with Trading on the OTCQB Venture Market Under Symbol BRCNF
Newsfile Corp
14:00
White House Highlights National Minority Quality Forum in Progress Report on Biden Cancer Moonshot
GlobeNewswire
13:52
Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results
GlobeNewswire
13:32
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
GlobeNewswire
13:30
PDD Holdings to Report First Quarter 2024 Unaudited Financial Results on May 22, 2024
GlobeNewswire
13:30
CORRECTION – Dragonfly Energy Reports First Quarter 2024 Financial and Operational Results
GlobeNewswire
13:30
DeFi Technologies Subsidiary Valour Inc. Launches World's First Yield Bearing Bitcoin (BTC) ETP in C...
GlobeNewswire
13:30
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with ...
GlobeNewswire
13:30
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with To...
GlobeNewswire
13:30
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página